GlobeNewswire by notified

DSV, 1062 - DSV announces changes to executive board


CompanyAnnouncement No. 1062

Group CEO Jens Bjørn Andersen to step down by 30 September 2024

The Board of Directors of DSV A/S announces changes to the Executive Board. Effective 30 September 2024, Group CEO Jens Bjørn Andersen will step down after 16 years in charge of the DSV Group. The current Group COO Jens H. Lund will assume the position of Group CEO of DSV A/S.

Jens H. Lund (born 1969) is a Danish citizen and has been a member of the Executive Board of DSV A/S since 2002, first as Group CFO and since 2021 as Group COO.

Thomas Plenborg, Chairman of the Board of Directors of DSV A/S:
"DSV has been on a fantastic journey under Jens Bjørn Andersen’s leadership since 2008. He has been instrumental in developing DSV into a leading global freight forwarder with excellent financial results and ultimately in creating significant value for DSV’s shareholders. It is a true privilege to work with Jens Bjørn and, on behalf of the Board of Directors, I would like to take the opportunity already now to thank him for his contribution over the years.

The Board of Directors believes that now is the right time to execute on the succession plan and announce Jens Lund as the future Group CEO. Jens Bjørn has agreed to continue as Group CEO until September 2024, supporting a good handover and continuity in the senior leadership team.

Jens Lund has been part of the Executive Board for many years, and he is known and respected both internally and externally as a visionary and strong leader. The Board of Directors is confident that Jens Lund is the right person to drive DSV’s continued growth strategy and further develop our global network, customer services and digital infrastructure.”

Jens Bjørn Andersen, Group CEO of DSV A/S:
“I am proud of the results that we have achieved as a team in DSV during my years as Group CEO. Through large acquisitions, integrations and challenging logistics markets, we have managed to support our customers, create value for our shareholders and – not least – to bring sustainability higher on the agenda. I would like to thank the Board of Directors, my leadership team and all my DSV colleagues for their trust and support throughout the years.”

Jens H. Lund, Group CEO of DSV A/S:
“I am honoured by the trust the Board of Directors is showing by giving me the opportunity to lead the next stages of DSV’s journey. I have truly enjoyed working with Jens Bjørn over the years, and with him in charge we have grown the company based on strong values and a unique corporate culture. Based on this solid foundation, I am looking forward, together with the DSV team, to continuing our growth path and taking us to the next level.”

Investor Relations: Flemming Ole Nielsen, tel. +45 43 20 33 92,
Media: Christian Krogslund, tel. +45 43 20 41 28,

Yours sincerely,


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

XPENG G9 Achieves a Five-Star 2023 Safety Rating from Euro NCAP6.12.2023 11:00:00 CET | Press release

The new XPENG G9, now on sale in Europe, received a five-star 2023 safety rating from Euro NCAPThis is XPENG's second five-star safety rating for an international model following the new P7 in October; and its first SUV obtained both Euro NCAP and C-NCAP five-star ratings AMSTERDAM, Dec. 06, 2023 (GLOBE NEWSWIRE) -- XPENG Motors (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announces that the international model of their flagship electric SUV, XPENG G9, has received a five-star 2023 safety rating from Euro NCAP. Euro NCAP's five-star safety rating system aims to help consumers, their families and businesses compare vehicles more easily and identify the safest choice for their needs. The tests, which replicate real-life road danger scenarios, represent the European gold standard for comprehensive automotive safety testing. The rating recognises the XPENG G9's advanced body structure and comprehensive passive s

AS Tallink Grupp: Managers’ Transactions6.12.2023 11:00:00 CET | Press release

Person subject to the notification requirement Name: AS Infortar Position: Closely associated person (X) Legal person Person Discharging Managerial Responsibilities in Issuer Name: Hanschmidt, Ain Position: Member of the Supervisory Board Name: Pant, Eve Position: Member of the Supervisory Board Issuer: AS Tallink Grupp LEI: 529900QRMWAKKR3L9W75 Notification type: Initial Notification _____________________________________ Transaction date: 04.12.2023 Venue: Nasdaq OMX Tallinn Instrument type: Share ISIN: EE3100004466 Nature of the transaction: Acquisition Transaction details: (1): Volume: 105,178; Unit price: 0.68 EUR Aggregated transactions: (2): Volume: 105,178; Volume weighted average price: 0.68 EUR Anneli Simm Investor Relations Manager AS Tallink Grupp Sadama 5 10111 Tallinn E-mail

CDR-Life Announces First Patient Dosed in Phase 1 Study with Boehringer Ingelheim Evaluating Potential Treatment for Geographic Atrophy6.12.2023 11:00:00 CET | Press release

ZÜRICH, Switzerland, Dec. 06, 2023 (GLOBE NEWSWIRE) -- CDR-Life Inc. today announced that the first patient has been dosed in the Phase 1 trial of BI 771716 for the treatment of geographic atrophy (GA). Licensed to Boehringer Ingelheim, BI 771716 is a highly specific antibody fragment of reduced size, enabling an optimized penetration through all retinal layers to the most critical target site driving GA disease pathology. The Phase 1 study (NCT06006585) is evaluating the safety, tolerability and pharmacokinetics of intravitreal single rising doses and multiple doses of BI 771716 as a potential treatment for GA. GA is a chronic and progressive, irreversible retinal disease that occurs in people with late-stage dry age-related macular degeneration (AMD) impacting the ability to see. More than 5 million people worldwide suffer from GA, of which more than 40% are legally blind. GA worsens with age, affecting 1 in 29 people above the age of 75 and 1 in 4 people above 90. Consequently, risi

ForFarmers N.V.: Approval competition authority for the acquisition of Piast Pasze Sp. z.o.o.6.12.2023 10:30:00 CET | Press release

Lochem, 6 December 2023 Approval competition authority for the acquisition of Piast Pasze Sp. z.o.o. Today, ForFarmers received approval from the Polish competition authority to acquire Piast Pasze Sp. z.o.o. ("Piast"). With this transaction, announced on 25 July 2023, ForFarmers/Tasomix's volume in Poland will expand by 410,000 tonnes, strengthening its position in the broiler sector in particular. Parties will work towards a closing of the acquisition. This transaction is in line with ForFarmers/Tasomix's strategic objectives to expand in the attractive Polish agricultural market. This press release contains information that qualifies as inside information within the meaning of Article 7 paragraph 1 of the EU Market Abuse Regulation. Note to the editor / For further information: Floor van Maaren, T: 06-29597746 Paweł Świerkula, Managing Director ForFarmers/Tasomix M + 48 510 22 00 22 • E: About ForFarmers ForFarmers N.V. is an international organisation tha